| Company Name | Fiscal Year | EPS (Estimated) | Revenue (Estimated) | Exchange | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Nov 17, 2026 |
|||||||||
| Q3 FY26 | $3.84 | $42.77B | |||||||
| Q4 FY26 | $1.69 | $25.23B | |||||||
|
QXO Inc
QXO
|
Q1 FY25 | $0.16 | $4.90B |
NYSE |
|||||
AECOM
ACM
|
Q4 FY26 | $1.57 | $1.92B |
NYSE |
|||||
|
Qnity Electronics
Q
|
Q3 FY26 | $1.18 | $1.49B |
NYSE |
|||||
|
Energizer Holdings
ENR
|
Q4 FY26 | $1.30 | $810.04M |
NYSE |
|||||
|
American Healthcare REIT
AHR
|
Q3 FY26 | $0.15 | $669.09M |
NYSE |
|||||
|
BellRing Brands
BRBR
|
Q4 FY26 | $0.21 | $656.84M |
NYSE |
|||||
|
La-Z-Boy
LZB
|
Q2 FY27 | $0.48 | $506.65M |
NYSE |
|||||
|
BKV
BKV
|
Q3 FY26 | $0.61 | $416.04M |
NYSE |
|||||
|
Dolby Laboratories
DLB
|
Q4 FY26 | $1.19 | $372.76M |
NYSE |
|||||
|
Guardian Pharmacy Services
GRDN
|
Q3 FY26 | $0.32 | $365.84M |
NYSE |
|||||
|
Legend Biotech
LEGN
|
Q3 FY26 | $0.01 | $361.43M |
NASDAQ |
|||||
|
Powell Industries
POWL
|
Q4 FY26 | $1.52 | $335.08M |
NASDAQ |
|||||
|
INNOVATE
VATE
|
Q2 FY26 | -$2.18 | $251.70M |
NYSE |
|||||
|
Varex Imaging
VREX
|
Q3 FY26 | $0.33 | $229.79M |
NASDAQ |
|||||
|
Nutex Health
NUTX
|
Q3 FY26 | $5.71 | $214.98M |
NASDAQ |
|||||
|
Golub Capital BDC
GBDC
|
Q4 FY26 | $0.33 | $187.49M |
NASDAQ |
|||||
|
Southland Holdings
SLND
|
Q3 FY26 | -$0.37 | $162.48M |
AMEX |
|||||
|
Oaktree Specialty Lending
OCSL
|
Q4 FY26 | $0.34 | $69.82M |
NASDAQ |
|||||
|
Capricor Therapeutics
CAPR
|
Q3 FY26 | $0.11 | $48.20M |
NASDAQ |
|||||
|
Strawberry Fields REIT LLC
STRW
|
Q3 FY26 | $0.17 | $40.89M |
AMEX |
|||||
|
Eagle Point Credit
ECC
|
Q3 FY26 | $0.17 | $38.86M |
NYSE |
|||||
|
Sonim Technologies
SONM
|
- | $5.04 | $36.06M |
NASDAQ |
|||||
|
PLBY Group
PLBY
|
Q3 FY26 | - | $30.35M |
NASDAQ |
|||||
|
CeriBell
CBLL
|
Q3 FY26 | -$0.51 | $29.16M |
NASDAQ |
|||||
|
SKYX Platforms
SKYX
|
Q3 FY26 | -$0.05 | $28.06M |
NASDAQ |
|||||
|
Gladstone Capital
GLAD
|
Q4 FY26 | $0.48 | $25.72M |
NASDAQ |
|||||
|
Northern Technologies International
NTIC
|
Q4 FY26 | $0.06 | $25.20M |
NASDAQ |
|||||
|
RDE
GIFT
|
- | -$0.02 | $22M |
NASDAQ |
|||||
|
TherapeuticsMD
TXMD
|
- | -$6.13 | $19.77M |
NASDAQ |
|||||
|
Crinetics Pharmaceuticals
CRNX
|
Q2 FY26 | -$1.17 | $18.97M |
NASDAQ |
|||||
|
SurgePays
SURG
|
Q1 FY26 | -$0.08 | $18.70M |
NASDAQ |
|||||
|
IRIDEX
IRIX
|
Q3 FY26 | -$0.04 | $12.65M |
NASDAQ |
|||||
|
Software Acquisition Group III
SWAG
|
Q3 FY26 | $0.02 | $11.24M |
NASDAQ |
|||||
|
KULR Technology Group
KULR
|
Q3 FY26 | -$0.08 | $10M |
AMEX |
|||||
|
PSQ Holdings
PSQH
|
Q2 FY26 | -$2.40 | $7.76M |
NYSE |
|||||
|
NEXGEL
NXGL
|
Q2 FY26 | -$0.04 | $6.90M |
NASDAQ |
|||||
|
OmniAb
OABI
|
Q3 FY26 | -$0.12 | $4.12M |
NASDAQ |
|||||
|
Helius Medical Technologies
HSDT
|
Q3 FY26 | $0.02 | $2.85M |
NASDAQ |
|||||
|
SHF Holdings
SHFS
|
- | $1.00 | $2.83M |
NASDAQ |
|||||
|
Opus Genetics
IRD
|
- | -$0.15 | $2.54M |
NASDAQ |
|||||
|
Nuwellis
NUWE
|
Q2 FY26 | -$13.65 | $2.51M |
NASDAQ |
|||||
|
NeurAxis
NRXS
|
Q3 FY26 | -$0.21 | $2.10M |
AMEX |
|||||
|
Intrusion
INTZ
|
Q3 FY26 | -$0.08 | $2M |
NASDAQ |
|||||
|
CXApp
CXAI
|
Q3 FY26 | -$0.06 | $1.70M |
NASDAQ |
|||||
|
Ascent Solar Technologies
ASTI
|
- | -$0.18 | $1.30M |
NASDAQ |
|||||
|
Femasys
FEMY
|
- | -$0.47 | $763K |
NASDAQ |
|||||
|
SAB Biotherapeutics
SABS
|
- | -$0.30 | $125K |
NASDAQ |
|||||
|
Perspective Therapeutics
CATX
|
- | -$0.25 | $78.04K |
AMEX |
|||||
|
iBio
IBIO
|
- | -$0.07 | $33.33K |
NASDAQ |
|||||
|
Indaptus Therapeutics
INDP
|
- | -$1.46 | - |
NASDAQ |
|||||
|
Spruce Power Holding
SPRU
|
Q2 FY26 | - | - |
NYSE |
|||||
|
Sadot Group
SDOT
|
Q3 FY25 | - | - |
NASDAQ |
|||||
|
Artelo Biosciences
ARTL
|
- | -$7.02 | - |
NASDAQ |
|||||
|
Intensity Therapeutics
INTS
|
Q3 FY26 | -$0.84 | - |
NASDAQ |
|||||
|
Alaunos Therapeutics
TCRT
|
- | -$15.75 | - |
NASDAQ |
|||||
|
FibroBiologics
FBLG
|
- | -$0.94 | - |
NASDAQ |
|||||
|
Theriva Biologics
TOVX
|
- | -$0.07 | - |
AMEX |
|||||
|
Reborn Coffee
REBN
|
- | - | - |
NASDAQ |
|||||
|
Belite Bio
BLTE
|
Q3 FY26 | -$0.82 | - |
NASDAQ |
|||||
| Show 51 more companies | |||||||||
